KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Income from Non-Controlling Interests (2016 - 2025)

Historic Income from Non-Controlling Interests for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to -$1.0 million.

  • Bristol Myers Squibb's Income from Non-Controlling Interests fell 12500.0% to -$1.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 million, marking a year-over-year decrease of 9333.33%. This contributed to the annual value of $2.0 million for FY2025, which is 8666.67% down from last year.
  • Bristol Myers Squibb's Income from Non-Controlling Interests amounted to -$1.0 million in Q4 2025, which was down 12500.0% from -$6.0 million recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Income from Non-Controlling Interests peaked at $8.0 million during Q1 2021, and registered a low of -$6.0 million during Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's median Income from Non-Controlling Interests value was $4.0 million (recorded in 2023), while the average stood at $3.8 million.
  • Per our database at Business Quant, Bristol Myers Squibb's Income from Non-Controlling Interests soared by 20000.0% in 2023 and then plummeted by 25000.0% in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Income from Non-Controlling Interests stood at $6.0 million in 2021, then tumbled by 50.0% to $3.0 million in 2022, then surged by 100.0% to $6.0 million in 2023, then crashed by 33.33% to $4.0 million in 2024, then plummeted by 125.0% to -$1.0 million in 2025.
  • Its Income from Non-Controlling Interests was -$1.0 million in Q4 2025, compared to -$6.0 million in Q3 2025 and $2.0 million in Q2 2025.